HomeNSB • ASX
add
Neuroscientific Biopharmaceuticals Ltd
Nakaraang pagsara
$0.14
Sakop ng araw
$0.12 - $0.14
Sakop ng taon
$0.033 - $0.26
Market cap
39.97M AUD
Average na Volume
301.63K
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (AUD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | — | — |
Gastos sa pagpapatakbo | 774.66K | 114.38% |
Net na kita | -738.98K | -195.08% |
Net profit margin | — | — |
Kita sa bawat share | — | — |
EBITDA | -750.80K | -199.08% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (AUD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 7.27M | 46.66% |
Kabuuang asset | 16.96M | 212.05% |
Kabuuang sagutin | 149.22K | 74.16% |
Kabuuang equity | 16.81M | — |
Natitirang share | 332.58M | — |
Presyo para makapag-book | 2.80 | — |
Return on assets | -11.41% | — |
Return on capital | -11.51% | — |
Cash Flow
Net change in cash
| (AUD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -738.98K | -195.08% |
Cash mula sa mga operasyon | -240.27K | -129.71% |
Cash mula sa pag-invest | -18.02K | — |
Cash mula sa financing | 1.64M | — |
Net change in cash | 1.39M | 71.38% |
Malayang cash flow | -61.40K | -112.37% |
Tungkol
Itinatag
2002
Website
